Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Rijke

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Clinical Epidemiology|March 27, 2025
GRADE notes 5: comparing a new intervention with an established treatment. Practical and methodological issuesFrancesco Nonino, Elisa Baldin, Nick Rijke, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 17, 2020
World Health Organization Essential Medicines List: Multiple sclerosis disease-modifying therapies applicationJennifer McDonell, Kathleen Costello, Joanna Laurson-Doube, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 13, 2021
Multiple Sclerosis International Federation guideline methodology for off-label treatments for multiple sclerosisThomas Piggott, Francesco Nonino, Elisa Baldin, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 26, 2021
Ethical use of off-label disease-modifying therapies for multiple sclerosisJoanna Laurson-Doube, Nick Rijke, Anne Helme, et al.
Frontiers in Neurology|April 6, 2026
Identifying knowledge gaps in reproductive health management for women with multiple sclerosis and healthcare professionals: a scoping reviewClaudia De Santis, Riley Bove, Dina Jacobs, et al.
Journal of Neurology|September 1, 2012
Future MS care: a consensus statement of the MS in the 21st Century Steering GroupPeter Rieckmann, Alexey Boyko, Diego Centonze, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 11, 2020
Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third editionClare Walton, Rachel King, Lindsay Rechtman, et al.
Multiple Sclerosis and Related Disorders|December 2, 2025
Recommendations for the use of off-label rituximab for the treatment of multiple sclerosis in low-resource settingsNick Rijke, Bassem I Yamout, Deanna Saylor, et al.
Multiple Sclerosis and Related Disorders|July 9, 2021
Changes on the health care of people with multiple sclerosis from Latin America during the COVID-19 pandemicAnibal Chertcoff, Johana Bauer, Berenice Anabel Silva, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 1, 2025
Recommendations for essential medicines for multiple sclerosis in low-resource settingsDeanna Saylor, Nick Rijke, Jennifer McDonell, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Clinical Epidemiology|March 27, 2025
GRADE notes 5: comparing a new intervention with an established treatment. Practical and methodological issuesFrancesco Nonino, Elisa Baldin, Nick Rijke, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 17, 2020
World Health Organization Essential Medicines List: Multiple sclerosis disease-modifying therapies applicationJennifer McDonell, Kathleen Costello, Joanna Laurson-Doube, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 13, 2021
Multiple Sclerosis International Federation guideline methodology for off-label treatments for multiple sclerosisThomas Piggott, Francesco Nonino, Elisa Baldin, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 26, 2021
Ethical use of off-label disease-modifying therapies for multiple sclerosisJoanna Laurson-Doube, Nick Rijke, Anne Helme, et al.
Frontiers in Neurology|April 6, 2026
Identifying knowledge gaps in reproductive health management for women with multiple sclerosis and healthcare professionals: a scoping reviewClaudia De Santis, Riley Bove, Dina Jacobs, et al.
Journal of Neurology|September 1, 2012
Future MS care: a consensus statement of the MS in the 21st Century Steering GroupPeter Rieckmann, Alexey Boyko, Diego Centonze, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 11, 2020
Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third editionClare Walton, Rachel King, Lindsay Rechtman, et al.
Multiple Sclerosis and Related Disorders|December 2, 2025
Recommendations for the use of off-label rituximab for the treatment of multiple sclerosis in low-resource settingsNick Rijke, Bassem I Yamout, Deanna Saylor, et al.
Multiple Sclerosis and Related Disorders|July 9, 2021
Changes on the health care of people with multiple sclerosis from Latin America during the COVID-19 pandemicAnibal Chertcoff, Johana Bauer, Berenice Anabel Silva, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 1, 2025
Recommendations for essential medicines for multiple sclerosis in low-resource settingsDeanna Saylor, Nick Rijke, Jennifer McDonell, et al.
Pageof 2